comprehensive -WSS

comprehensive

author：entertainment 2025-09-28 02:28:01 - browse：418

The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder.

The new medicine, called Casgevy, is made by Vertex Pharmaceuticals and CRISPR Therapeutics. Its authorization is a scientific triumph for the technology that can efficiently and precisely repair DNA mutations — ushering in a new era of genetic medicines for inherited diseases.

In a clinical trial, Casgevy was shown to eliminate recurrent episodes of debilitating pain caused by sickle cell, which afflicts approximately 100,000 people in the U.S., a vast majority of whom are Black. The therapy, whose scientific name is exa-cel, is described as a potential cure because the genetic fix enabled by CRISPR is designed to last a lifetime, although confirmation will require years of follow-up.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： U.K. officials, researchers try to ease path for bespoke genetic treatments

WSS

Erich Jarvis studies song birds to learn about human stuttering

South Korea throws huge K

Anavex keeps shifting the goalposts in its clinical trials

Readout Newsletter: Illumina, CRISPR, Regeneron

Readout Newsletter: Illumina, CRISPR, Regeneron

Steward Health Care expansion into Malta flopped

entertainment

comprehensive

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Why failed clinical trials don’t always spell doom for a new drug

At least 13 dead in Texas as scorching temps continue

'Patient friction coefficient' can gauge a clinical trial's patient burden

Tori Bowie and the unacceptable rates of Black maternal death

The best solution to the drug shortages problem

ChatGPT in medicine: STAT answers readers' burning questions

Maui's cultural, historic landmarks damaged in the devastating wildfires

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

leisure time

6 surprising facts about sugar

Yancopoulos of Regeneron works to expand Dupixent success

Erich Jarvis studies song birds to learn about human stuttering

U.K. officials, researchers try to ease path for bespoke genetic treatments

Friends ask where James Watson's attitudes about race came from

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

hotspot

entertainment

leisure time

Wikipedia